We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSPD icon
4401
PUT
Lightspeed Commerce
LSPD
$1.38B
$4.79M ﹤0.01%
57,300
-7,100
-11% -$499K
BIB icon
4402
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
$4.79M ﹤0.01%
48,600
+25,700
+112% +$2.24M
NOV icon
4403
CALL
NOV
NOV
$7.54B
$4.79M ﹤0.01%
312,500
+173,100
+124% +$2.69M
RDUS
4404
PUT
DELISTED
Radius Recycling
RDUS
$4.78M ﹤0.01%
97,500
+80,000
+457% +$3.98M
MSGS icon
4405
CALL
Madison Square Garden
MSGS
$9.8B
$4.78M ﹤0.01%
27,700
-4,400
-14% -$795K
SYNA icon
4406
PUT
Synaptics
SYNA
$4.25B
$4.78M ﹤0.01%
30,700
+7,700
+33% +$1.04M
LITS
4407
Lite Strategy Inc
LITS
$30.2M
$4.78M ﹤0.01%
83,771
-33,341
-28% -$2.14M
CRL icon
4408
PUT
Charles River Laboratories
CRL
$13.4B
$4.77M ﹤0.01%
12,900
-8,700
-40% -$2.91M
BLMN icon
4409
CALL
Bloomin' Brands
BLMN
$903M
$4.77M ﹤0.01%
175,800
+31,100
+21% +$880K
SNDL icon
4410
CALL
Sundial Growers
SNDL
$313M
$4.77M ﹤0.01%
502,780
+191,530
+62% +$1.75M
AEIS icon
4411
CALL
Advanced Energy
AEIS
$13.2B
$4.77M ﹤0.01%
42,300
+1,400
+3% +$148K
FWONA icon
4412
Liberty Media Series A
FWONA
$23.9B
$4.77M ﹤0.01%
116,817
-2,406
-2% -$93.2K
RITM icon
4413
CALL
Rithm Capital
RITM
$5.79B
$4.77M ﹤0.01%
450,100
-35,000
-7% -$372K
TMPMU
4414
DELISTED
Turmeric Acquisition Corp. Unit
TMPMU
$4.76M ﹤0.01%
459,420
+444
+0.1% +$4.46K
EPAY
4415
DELISTED
Bottomline Technologies Inc
EPAY
$4.76M ﹤0.01%
128,509
+7,060
+6% +$291K
COHR
4416
DELISTED
Coherent Inc
COHR
$4.76M ﹤0.01%
18,024
+1,003
+6% +$264K
IRDM icon
4417
CALL
Iridium Communications
IRDM
$5.32B
$4.75M ﹤0.01%
118,900
-12,700
-10% -$493K
FLWS icon
4418
1-800-Flowers.com
FLWS
$262M
$4.75M ﹤0.01%
149,106
-58,927
-28% -$1.84M
PCRX icon
4419
Pacira BioSciences
PCRX
$917M
$4.75M ﹤0.01%
78,314
+32,964
+73% +$2.09M
PPH icon
4420
VanEck Pharmaceutical ETF
PPH
$985M
$4.75M ﹤0.01%
65,028
+7,279
+13% +$519K
THS
4421
DELISTED
Treehouse Foods
THS
$4.75M ﹤0.01%
106,683
+88,131
+475% +$4.35M
TWNI.U
4422
DELISTED
Tailwind International Acquisition Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
TWNI.U
$4.75M ﹤0.01%
475,000
-659,620
-58% -$6.58M
SNDL icon
4423
Sundial Growers
SNDL
$313M
$4.75M ﹤0.01%
500,449
+156,432
+45% +$1.43M
HYFM icon
4424
PUT
Hydrofarm Holdings
HYFM
$7M
$4.75M ﹤0.01%
8,030
+3,660
+84% +$2.15M
INSG icon
4425
PUT
Inseego
INSG
$77M
$4.75M ﹤0.01%
47,050
-19,690
-30% -$1.8M

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.